We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Altria Group Inc | NYSE:MO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.1993 | 0.45% | 44.0193 | 44.21 | 43.825 | 44.00 | 9,054,915 | 01:00:00 |
From May 2022 to May 2024
By Will Feuer
The Food and Drug Administration authorized Altria Group Inc.-owned U.S. Smokeless Tobacco Co.'s Copenhagen Classic Snuff product to be marketed as a modified-risk tobacco product, or MRTP.
The authorization means that the product, which is a smokeless tobacco product, can be marketed with the language: "IF YOU SMOKE, CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer."
The FDA said its staff reviewed available evidence, public comments and recommendations from expert committees and concluded that the claim in the language is accurate.
The company is still required to conduct postmarket surveillance. The modified-risk granted order will expire in five years and the company will need to receive authorization then to continue to market the product as a MRTP, the FDA said.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
March 16, 2023 12:02 ET (16:02 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Altria Chart |
1 Month Altria Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
